

Dr Kieron Lim
Senior Consultant Gastroenterologist & Hepatologist
MBBS, University of London, Member, Royal College of Physicians (UK), Fellow, Academy of Medicine (Gastroenterology) Singapore, Fellow, Royal College of Physicians (Edinburgh)
Atrophic gastritis can be partially reversed in some cases, particularly when the underlying cause is treated before extensive damage develops in the stomach lining. However, complete reversal is not always possible, as advanced atrophy and intestinal metaplasia can persist even after successful treatment.
Understanding which changes are potentially reversible and which may require long-term monitoring can help patients establish realistic treatment expectations and take appropriate steps to manage the condition.
Atrophic gastritis is a form of chronic gastritis in which ongoing inflammation causes the gradual loss of normal glands in the stomach lining. It is most commonly associated with long-term Helicobacter pylori (H. pylori) infection or an autoimmune response.
H. pylori can spread through contact with an infected person or contaminated food or water and may persist for years if untreated. Autoimmune atrophic gastritis develops when the immune system mistakenly attacks healthy stomach cells, although the exact reason this response occurs is not fully understood.
These two causes have different implications for treatment and recovery. While H. pylori infection can be eliminated with appropriate medication, autoimmune atrophic gastritis generally requires ongoing management. Establishing the underlying cause is therefore an important part of determining what improvement may be possible.
Treatment for atrophic gastritis focuses on reducing its harmful effects on the stomach lining. Both approaches aim to limit further damage and manage the consequences of the condition, although their ability to address the underlying cause and support recovery differs.
If H. pylori infection is present, treatment aims to eliminate the bacteria and stop it from causing further inflammation. This usually involves a combination of antibiotics and acid-reducing medication prescribed by a doctor.
After treatment, testing may be recommended to confirm that the infection has cleared. Some atrophic changes may improve following successful H. pylori treatment, although more advanced changes can persist.
Autoimmune atrophic gastritis is managed through ongoing monitoring and treatment of complications, particularly vitamin B12 and iron deficiencies. As there is currently no established treatment to stop the underlying autoimmune response, care focuses on addressing its effects rather than reversing the cause itself.
This may involve blood tests to monitor nutrient levels, vitamin B12 replacement or iron supplementation when deficiencies are identified. Ongoing assessment may also be recommended to monitor changes in the stomach lining and associated risks.
The stomach lining may be able to recover from some of the changes caused by atrophic gastritis if the condition is identified and treated before extensive damage develops. Earlier or less extensive changes may have a greater chance of improving once the underlying cause of inflammation is addressed.
More extensive atrophy or established intestinal metaplasia may be less likely to improve and can persist even after the underlying cause is treated. This is why treatment is generally aimed not only at relieving symptoms but also at addressing the cause and monitoring relevant changes over time.
Doctors assess atrophic gastritis by reviewing the patient's medical history, evaluating symptoms and examining the stomach lining for signs of gland loss and other changes. Several tests may be used to confirm the condition, investigate its underlying cause and determine the appropriate treatment approach.
Blood tests may also be recommended to check for vitamin B12 or iron deficiency and investigate a possible autoimmune cause. Together, these findings help doctors assess the condition and determine whether treatment or ongoing monitoring is needed.

Taking an active approach to atrophic gastritis can help you protect your digestive health over time. Even when some changes cannot be fully reversed, continued monitoring remains important for identifying nutritional deficiencies, assessing persistent changes and managing the associated risk of stomach cancer.
At Kieron Lim Gastroenterology, Dr Kieron Lim, senior consultant gastroenterologist & hepatologist, provides assessment and management of stomach conditions, including atrophic gastritis. Through gastroscopy, appropriate testing and individualised follow-up recommendations, he can help patients understand the extent of their condition, address underlying causes and plan ongoing care.
If you have been diagnosed with atrophic gastritis or require further assessment of persistent stomach concerns, contact us today to arrange a consultation.

Meet Our Doctor
Dr Kieron Lim
Senior Consultant Gastroenterologist & Hepatologist
MBBS, University of London Member, Royal College of Physicians (UK) Fellow, Academy of Medicine (Gastroenterology) Singapore Fellow, Royal College of Physicians (Edinburgh)
Dr Kieron Lim is a senior consultant gastroenterologist & hepatologist who provides comprehensive care for patients with gastrointestinal conditions in Singapore. His expertise extends to disorders affecting the oesophagus, stomach, colon, liver, pancreas and gallbladder. Through his experience, Dr Lim enhances patient outcomes by facilitating early detection and timely medical interventions.